1 – 10 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
The remote exercise SWEDEHEART study–Rationale and design of a multicenter registry-based cluster randomized crossover clinical trial (RRCT)
(
- Contribution to journal › Article
-
Mark
A cross-stakeholder approach to improving out-of-hospital cardiac arrest survival
(
- Contribution to journal › Article
-
Mark
Rationale and design of the DAPA-MI trial : Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction
(
- Contribution to journal › Article
- 2022
-
Mark
Rationale and design of switch Swedeheart : A registry-based, stepped-wedge, cluster-randomized, open-label multicenter trial to compare prasugrel and ticagrelor for treatment of patients with acute coronary syndrome
(
- Contribution to journal › Article
- 2021
-
Mark
Growth differentiation factor-15 is a biomarker for all-cause mortality but less evident for cardiovascular outcomes : A prospective study
(
- Contribution to journal › Article
-
Mark
Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction : Sex-related outcomes from DETO2X-AMI
(
- Contribution to journal › Article
-
Mark
Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction
(
- Contribution to journal › Article
-
Mark
Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT) : Rationale and design: MINOCA-BAT: Rationale and design
(
- Contribution to journal › Article
- 2020
-
Mark
Accelerated treatment of endocarditis—The POET II trial : Rationale and design of a randomized controlled trial: Design and rationale of the POET II trial
(
- Contribution to journal › Article